| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3852996 | Diálisis y Trasplante | 2015 | 7 Pages |
Abstract
The combination of simvastatin plus ezetimibe in CKD patients appears to be effective in lipid control at least in this follow-up period. No serious side effects associated have been observed. Demonstrating a reduction in cardiovascular risk associated with greater control of lipid levels requires a longer period of monitoring.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
José Luis Merino, Erika Lozano, Patricia DomÃnguez, Yésika Amézquita, Blanca Bueno, Beatriz Espejo, Vicente ParaÃso,